Greenwich LifeSciences, Inc. (GLSI)

NASDAQ: GLSI · Real-Time Price · USD

21.65

-0.60 (-2.70%)

At close: Jun 8, 2026, 4:00 PM EDT

21.72

+0.07 (0.32%)

After-hours: Jun 8, 2026, 7:40 PM EDT

Greenwich LifeSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	318	300	148	135	195	320
Market Cap Growth	144.31%	103.38%	9.28%	-30.79%	-38.95%	-30.95%
Enterprise Value	307.28	294.23	143.61	128.17	181.82	292.68
Last Close Price	21.65	21.01	11.23	10.52	15.20	24.33
PB Ratio	60.25	850.50	162.56	20.17	14.78	11.92
P/TBV Ratio	55.51	805.09	160.85	20.17	14.86	11.74
Net Debt / Equity Ratio	-1.99	-17.49	-4.50	-1.04	-1.02	-1.01
Net Debt / EBITDA Ratio	0.48	0.32	0.23	0.75	1.68	5.92
Net Debt / FCF Ratio	0.82	0.62	0.56	1.08	2.17	6.34
Quick Ratio	2.01	1.06	1.28	23.74	51.23	70.63
Current Ratio	2.01	1.06	1.28	23.74	51.23	70.63
Return on Equity (ROE)	-773.80%	-3068.25%	-457.73%	-89.30%	-39.08%	-16.78%
Return on Assets (ROA)	-262.43%	-378.67%	-318.12%	-91.13%	-39.52%	-16.45%
Return on Invested Capital (ROIC)	-2611.53%	-2915.09%	-8252.18%	-19732.50%	-7052.70%	-1742.67%
Return on Capital Employed (ROCE)	-778.58%	-3082.46%	-463.59%	-93.68%	-40.16%	-16.88%
Buyback Yield / Dilution	-6.04%	-4.00%	-1.30%	0.51%	0.23%	-36.27%
Total Shareholder Return	-6.04%	-4.00%	-1.30%	0.51%	0.23%	-36.27%

SEC Filings: 10-K · 10-Q